Federal award (PURCHASE ORDER, fiscal year 2022)
Recipient: DEXORGEN INC.
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2023-09-12 to 2023-09-27
Current total value of award: $22620
Description: EXPI293 STABLE CELL LINE OVEREXPRESSING HTLV ENVELOPE PROTEIN (AMBIS #2183770)